Retasturtide is a recently launched novel GLP-1 receptor agonist demonstrating promising results in the management of type 2 diabetes. This artificial peptide resembles the actions of naturally present GLP-1, a hormone that plays a crucial role in regulating blood insulin response. By enhancing GLP-1 get more info receptors in the pancreas, Retast